Global Small-Molecule Drug Discovery Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Small-Molecule Drug Discovery market report explains the definition, types, applications, major countries, and major players of the Small-Molecule Drug Discovery market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • GlaxoSmithKline

    • Merck

    • Teva Pharmaceuticals

    • Johnson & Johnson

    • Bristol-Myers Squibb

    • Gilead Sciences Inc

    • Boehringer Ingelheim

    • Pfizer

    • AstraZeneca

    By Type:

    • Pills

    • Tablets

    • Other

    By End-User:

    • Oncology

    • Cardiovascular

    • Dermatology

    • Central Nervous System

    • Respiratory

    • Gastrointestinal

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Small-Molecule Drug Discovery Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Small-Molecule Drug Discovery Outlook to 2028- Original Forecasts

    • 2.2 Small-Molecule Drug Discovery Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Small-Molecule Drug Discovery Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Small-Molecule Drug Discovery Market- Recent Developments

    • 6.1 Small-Molecule Drug Discovery Market News and Developments

    • 6.2 Small-Molecule Drug Discovery Market Deals Landscape

    7 Small-Molecule Drug Discovery Raw Materials and Cost Structure Analysis

    • 7.1 Small-Molecule Drug Discovery Key Raw Materials

    • 7.2 Small-Molecule Drug Discovery Price Trend of Key Raw Materials

    • 7.3 Small-Molecule Drug Discovery Key Suppliers of Raw Materials

    • 7.4 Small-Molecule Drug Discovery Market Concentration Rate of Raw Materials

    • 7.5 Small-Molecule Drug Discovery Cost Structure Analysis

      • 7.5.1 Small-Molecule Drug Discovery Raw Materials Analysis

      • 7.5.2 Small-Molecule Drug Discovery Labor Cost Analysis

      • 7.5.3 Small-Molecule Drug Discovery Manufacturing Expenses Analysis

    8 Global Small-Molecule Drug Discovery Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Small-Molecule Drug Discovery Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Small-Molecule Drug Discovery Export by Region (Top 10 Countries) (2017-2028)

    9 Global Small-Molecule Drug Discovery Market Outlook by Types and Applications to 2022

    • 9.1 Global Small-Molecule Drug Discovery Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Pills Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Tablets Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Small-Molecule Drug Discovery Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cardiovascular Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Dermatology Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Central Nervous System Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Respiratory Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Gastrointestinal Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Small-Molecule Drug Discovery Market Analysis and Outlook till 2022

    • 10.1 Global Small-Molecule Drug Discovery Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.2.2 Canada Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.2.3 Mexico Small-Molecule Drug Discovery Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.3.2 UK Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.3.3 Spain Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.3.4 Belgium Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.3.5 France Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.3.6 Italy Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.3.7 Denmark Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.3.8 Finland Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.3.9 Norway Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.3.10 Sweden Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.3.11 Poland Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.3.12 Russia Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.3.13 Turkey Small-Molecule Drug Discovery Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.4.2 Japan Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.4.3 India Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.4.4 South Korea Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.4.5 Pakistan Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.4.6 Bangladesh Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.4.7 Indonesia Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.4.8 Thailand Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.4.9 Singapore Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.4.10 Malaysia Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.4.11 Philippines Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.4.12 Vietnam Small-Molecule Drug Discovery Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.5.2 Colombia Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.5.3 Chile Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.5.4 Argentina Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.5.5 Venezuela Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.5.6 Peru Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.5.7 Puerto Rico Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.5.8 Ecuador Small-Molecule Drug Discovery Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.6.2 Kuwait Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.6.3 Oman Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.6.4 Qatar Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Small-Molecule Drug Discovery Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.7.2 South Africa Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.7.3 Egypt Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.7.4 Algeria Small-Molecule Drug Discovery Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Small-Molecule Drug Discovery Consumption (2017-2022)

      • 10.8.2 New Zealand Small-Molecule Drug Discovery Consumption (2017-2022)

    11 Global Small-Molecule Drug Discovery Competitive Analysis

    • 11.1 GlaxoSmithKline

      • 11.1.1 GlaxoSmithKline Company Details

      • 11.1.2 GlaxoSmithKline Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 GlaxoSmithKline Small-Molecule Drug Discovery Main Business and Markets Served

      • 11.1.4 GlaxoSmithKline Small-Molecule Drug Discovery Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Merck

      • 11.2.1 Merck Company Details

      • 11.2.2 Merck Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Merck Small-Molecule Drug Discovery Main Business and Markets Served

      • 11.2.4 Merck Small-Molecule Drug Discovery Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Teva Pharmaceuticals

      • 11.3.1 Teva Pharmaceuticals Company Details

      • 11.3.2 Teva Pharmaceuticals Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Teva Pharmaceuticals Small-Molecule Drug Discovery Main Business and Markets Served

      • 11.3.4 Teva Pharmaceuticals Small-Molecule Drug Discovery Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Johnson & Johnson

      • 11.4.1 Johnson & Johnson Company Details

      • 11.4.2 Johnson & Johnson Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Johnson & Johnson Small-Molecule Drug Discovery Main Business and Markets Served

      • 11.4.4 Johnson & Johnson Small-Molecule Drug Discovery Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Bristol-Myers Squibb

      • 11.5.1 Bristol-Myers Squibb Company Details

      • 11.5.2 Bristol-Myers Squibb Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Bristol-Myers Squibb Small-Molecule Drug Discovery Main Business and Markets Served

      • 11.5.4 Bristol-Myers Squibb Small-Molecule Drug Discovery Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Gilead Sciences Inc

      • 11.6.1 Gilead Sciences Inc Company Details

      • 11.6.2 Gilead Sciences Inc Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Gilead Sciences Inc Small-Molecule Drug Discovery Main Business and Markets Served

      • 11.6.4 Gilead Sciences Inc Small-Molecule Drug Discovery Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Boehringer Ingelheim

      • 11.7.1 Boehringer Ingelheim Company Details

      • 11.7.2 Boehringer Ingelheim Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Boehringer Ingelheim Small-Molecule Drug Discovery Main Business and Markets Served

      • 11.7.4 Boehringer Ingelheim Small-Molecule Drug Discovery Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Pfizer

      • 11.8.1 Pfizer Company Details

      • 11.8.2 Pfizer Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Pfizer Small-Molecule Drug Discovery Main Business and Markets Served

      • 11.8.4 Pfizer Small-Molecule Drug Discovery Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 AstraZeneca

      • 11.9.1 AstraZeneca Company Details

      • 11.9.2 AstraZeneca Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 AstraZeneca Small-Molecule Drug Discovery Main Business and Markets Served

      • 11.9.4 AstraZeneca Small-Molecule Drug Discovery Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Small-Molecule Drug Discovery Market Outlook by Types and Applications to 2028

    • 12.1 Global Small-Molecule Drug Discovery Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Pills Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Tablets Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Small-Molecule Drug Discovery Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Dermatology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Central Nervous System Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Respiratory Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Small-Molecule Drug Discovery Market Analysis and Outlook to 2028

    • 13.1 Global Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.2.2 Canada Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.2 UK Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.3 Spain Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.5 France Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.6 Italy Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.8 Finland Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.9 Norway Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.11 Poland Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.12 Russia Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.2 Japan Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.3 India Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.3 Chile Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.6 Peru Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.6.3 Oman Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Small-Molecule Drug Discovery Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Small-Molecule Drug Discovery

    • Figure of Small-Molecule Drug Discovery Picture

    • Table Global Small-Molecule Drug Discovery Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Small-Molecule Drug Discovery Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Pills Consumption and Growth Rate (2017-2022)

    • Figure Global Tablets Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)

    • Figure Global Dermatology Consumption and Growth Rate (2017-2022)

    • Figure Global Central Nervous System Consumption and Growth Rate (2017-2022)

    • Figure Global Respiratory Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Small-Molecule Drug Discovery Consumption by Country (2017-2022)

    • Table North America Small-Molecule Drug Discovery Consumption by Country (2017-2022)

    • Figure United States Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Canada Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Mexico Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table Europe Small-Molecule Drug Discovery Consumption by Country (2017-2022)

    • Figure Germany Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure UK Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Spain Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Belgium Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure France Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Italy Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Denmark Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Finland Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Norway Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Sweden Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Poland Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Russia Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Turkey Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table APAC Small-Molecule Drug Discovery Consumption by Country (2017-2022)

    • Figure China Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Japan Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure India Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure South Korea Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Thailand Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Singapore Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Philippines Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table South America Small-Molecule Drug Discovery Consumption by Country (2017-2022)

    • Figure Brazil Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Colombia Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Chile Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Argentina Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Peru Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table GCC Small-Molecule Drug Discovery Consumption by Country (2017-2022)

    • Figure Bahrain Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Oman Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Qatar Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table Africa Small-Molecule Drug Discovery Consumption by Country (2017-2022)

    • Figure Nigeria Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure South Africa Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Egypt Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Algeria Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table Oceania Small-Molecule Drug Discovery Consumption by Country (2017-2022)

    • Figure Australia Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Small-Molecule Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Small-Molecule Drug Discovery Main Business and Markets Served

    • Table GlaxoSmithKline Small-Molecule Drug Discovery Product Portfolio

    • Table Merck Company Details

    • Table Merck Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Small-Molecule Drug Discovery Main Business and Markets Served

    • Table Merck Small-Molecule Drug Discovery Product Portfolio

    • Table Teva Pharmaceuticals Company Details

    • Table Teva Pharmaceuticals Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceuticals Small-Molecule Drug Discovery Main Business and Markets Served

    • Table Teva Pharmaceuticals Small-Molecule Drug Discovery Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Small-Molecule Drug Discovery Main Business and Markets Served

    • Table Johnson & Johnson Small-Molecule Drug Discovery Product Portfolio

    • Table Bristol-Myers Squibb Company Details

    • Table Bristol-Myers Squibb Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Small-Molecule Drug Discovery Main Business and Markets Served

    • Table Bristol-Myers Squibb Small-Molecule Drug Discovery Product Portfolio

    • Table Gilead Sciences Inc Company Details

    • Table Gilead Sciences Inc Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Inc Small-Molecule Drug Discovery Main Business and Markets Served

    • Table Gilead Sciences Inc Small-Molecule Drug Discovery Product Portfolio

    • Table Boehringer Ingelheim Company Details

    • Table Boehringer Ingelheim Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Small-Molecule Drug Discovery Main Business and Markets Served

    • Table Boehringer Ingelheim Small-Molecule Drug Discovery Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Small-Molecule Drug Discovery Main Business and Markets Served

    • Table Pfizer Small-Molecule Drug Discovery Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Small-Molecule Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Small-Molecule Drug Discovery Main Business and Markets Served

    • Table AstraZeneca Small-Molecule Drug Discovery Product Portfolio

    • Figure Global Pills Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dermatology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Central Nervous System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Respiratory Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Small-Molecule Drug Discovery Consumption Forecast by Country (2022-2028)

    • Table North America Small-Molecule Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure United States Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Small-Molecule Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure Germany Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Small-Molecule Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure China Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Small-Molecule Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure Brazil Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Small-Molecule Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Small-Molecule Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Small-Molecule Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure Australia Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Small-Molecule Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.